New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A5853

Introduced
12/11/23  

Caption

Appropriates $2.5 million to DOBI to reimburse joint insurance funds for COVID-19 surveillance testing.

Impact

The implementation of A5853 is intended to alleviate some financial strain on joint insurance funds that acted beyond the mandated federal guidelines to provide coverage for COVID-19 testing. By facilitating reimbursement to these funds, the bill supports the continued operation of health-related employers under pandemic conditions, ensuring that covered workers could maintain their employment while adhering to testing or vaccination policies. This legislative move may foster a more comprehensive response to healthcare issues emerging from the pandemic, though its effectiveness will depend on the uptake of the reimbursement process and the ongoing management of related funds.

Summary

Bill A5853 was introduced in the New Jersey legislature to address the financial burden faced by joint insurance funds that provided coverage for COVID-19 surveillance testing during a specified period. The bill proposes an appropriation of $2.5 million from the General Fund to the Department of Banking and Insurance (DOBI) specifically for reimbursing these funds. This is aimed at covering the costs incurred due to requirements for some employers to ensure proof of vaccination or conduct regular surveillance testing for their employees, particularly in healthcare and high-risk congregate settings, between August 6, 2021, and August 15, 2022.

Contention

While the bill appears to be largely supportive of joint insurance funds, it could be contentious among different stakeholders. Proponents argue that it provides necessary support to ensure that institutions tackling COVID-19 are not penalized for going above minimal requirements during a public health crisis. Conversely, there could be concerns raised about the appropriateness of using public funds for insurance reimbursements and the long-term financial implications for the state's budget. Some may question whether this sets a precedent for future appropriations related to health emergencies.

Companion Bills

No companion bills found.

Previously Filed As

NJ A970

Appropriates $2.5 million to DOBI to reimburse joint insurance funds for COVID-19 surveillance testing.

NJ A1731

Requires key boxes at public school buildings with certain exceptions; appropriates $2.5 million for reimbursement of costs related to key box installation.

NJ A845

Restricts establishment of mandates to become vaccinated against coronavirus disease 2019 (COVID-19); establishes reimbursement program to cover certain out-of-pocket costs incurred in obtaining COVID-19 vaccine.

NJ S1025

Establishes Commission on Insurance Reimbursement.

NJ HB540

AN ACT relating to coverage for COVID-19 testing.

NJ A2663

Establishes child care costs reimbursement grant program in DCF; appropriates $500,000.

NJ HB366

Provide appropriation to DOJ for Lake County reimbursement related to PL 280

NJ S2644

Increases FY2026 annual appropriation to DCF by $16.7 million to increase NJ FamilyCare monthly reimbursement rate paid to care management organizations.

NJ A2327

Increases FY2026 annual appropriation to DCF by $16.7 million to increase NJ FamilyCare monthly reimbursement rate paid to care management organizations.

NJ SB317

Wastewater surveillance.

Similar Bills

No similar bills found.